We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACGA
201
Atlanta Consulting Group Advisors
Georgia
$126K – – –
C
202
Covestor
United Kingdom
$121K +$108K +9,425 +4,883%
Royal Bank of Canada
203
Royal Bank of Canada
Ontario, Canada
$118K -$17.5M -1,529,485 -99%
GRP
204
Global Retirement Partners
California
$115K +$105K +9,145 New
BG
205
Bellevue Group
Switzerland
$99.7K – – –
MCA
206
McGuire Capital Advisors
Oklahoma
$83.4K +$75.7K +6,620 New
Nisa Investment Advisors
207
Nisa Investment Advisors
Missouri
$82.4K -$4.58K -400 -6%
GFM
208
GF Fund Management
China
$77.8K -$6.63K -579 -9%
AB
209
Amalgamated Bank
New York
$60K -$8.96K -783 -14%
Comerica Bank
210
Comerica Bank
Texas
$59.1K +$19.3K +1,685 +56%
SEP
211
Signature Equity Partners
Ohio
$54.2K +$49.3K +4,305 New
EIM
212
Essex Investment Management
Massachusetts
$54.1K +$49.1K +4,295 New
RIL
213
Rothschild Investment LLC
Illinois
$53.8K +$183 +16 +0.4%
SO
214
STRS Ohio
Ohio
$51.7K +$46.9K +4,100 New
EP
215
Essential Partners
California
$40.7K +$160 +14 +0.4%
ETC
216
Exchange Traded Concepts
Oklahoma
$40.6K +$1.34K +117 +4%
TFA
217
Transamerica Financial Advisors
Florida
$36.7K +$28.1K +2,460 +542%
SWM
218
Spire Wealth Management
Virginia
$32.2K +$11.7K +1,023 +67%
S
219
SignatureFD
Georgia
$31K – – –
VCM
220
Versant Capital Management
Arizona
$30.7K – – –
Federated Hermes
221
Federated Hermes
Pennsylvania
$28.9K +$24.8K +2,168 +1,681%
KAS
222
Kemnay Advisory Services
New York
$26K +$23.6K +2,060 New
Ohio Public Employees Retirement System (OPERS)
223
Ohio Public Employees Retirement System (OPERS)
Ohio
$25.1K -$5.29K -462 -19%
MCM
224
MAI Capital Management
Ohio
$22.1K +$11 +1 +0.1%
HCA
225
Harbor Capital Advisors
Illinois
$21K -$320 -28 -2%
7 8
9
10 11

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.